Zobrazeno 1 - 10
of 401
pro vyhledávání: '"Vincent PH"'
Autor:
Zelic R, Giunchi F, Fridfeldt J, Carlsson J, Davidsson S, Lianas L, Mascia C, Zugna D, Molinaro L, Vincent PH, Zanetti G, Andrén O, Richiardi L, Akre O, Fiorentino M, Pettersson A
Publikováno v:
Clinical Epidemiology, Vol Volume 14, Pp 59-70 (2022)
Externí odkaz:
https://doaj.org/article/4ae510717206439d9630d594dc20ae72
Autor:
Droz-Vincent, Ph.
Publikováno v:
Phys.Rev.A73:042101,2006
Three-body systems of scalar bosons are described in the framework of relativistic constraint dynamics. With help of a change of variables followed by a change of wave function, two redundant degrees of freedom get eliminated and the mass-shell const
Externí odkaz:
http://arxiv.org/abs/hep-th/0505163
Autor:
Droz-Vincent, Ph.
Publikováno v:
Int.J.Theor.Phys.42:1809-1834,2003
The Klein-Gordon system describing three scalar particles without interaction is cast into a new form, by transformation of the momenta. Two redundant degrees of freedom are eliminated; we are left with a covariant equation for a reduced wave functio
Externí odkaz:
http://arxiv.org/abs/hep-th/9905119
Autor:
Droz-Vincent, Ph.
Klein-Gordon equation with minimal coupling in FRW-like spacetimes with compact but not necessarily isotropic neither homogeneous space sections. Beside exceptional cases, the kernel is invariant under continuous isometries.
Comment: Latex file,
Comment: Latex file,
Externí odkaz:
http://arxiv.org/abs/gr-qc/9812048
Autor:
Droz-Vincent, Ph.
We consider the Klein-Gordon equation in FRW-like spacetimes, with compact space sections (not necessarily isotropic neither homogeneous). The bi-scalar kernel allowing to select the positive-frequency part of any solution is developed on mode soluti
Externí odkaz:
http://arxiv.org/abs/gr-qc/9801007
Autor:
Rautiola J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. juhana.rautiola@ki.se.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden. juhana.rautiola@ki.se., Björklund J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Zelic R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Edgren G; Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Cardiology, Södersjukhuset, Stockholm, Sweden., Bottai M; Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Nilsson M; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden., Vincent PH; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Fredholm H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Falconer H; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Sjövall A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Nilsson PJ; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Wiklund P; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA., Aly M; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Akre O; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2024 Mar; Vol. 31 (3), pp. 1739-1748. Date of Electronic Publication: 2023 Dec 13.
Autor:
Rautiola J; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden. juhana.rautiola@ki.se., Björklund J; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Zelic R; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Edgren G; Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet and Department of Cardiology, Södersjukhuset, Stockholm, Sweden., Bottai M; Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Nilsson M; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden., Vincent PH; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Fredholm H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Falconer H; Department of Pelvic Cancer, Karolinska University Hospital and Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Sjövall A; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Nilsson PJ; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Wiklund P; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Aly M; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Akre O; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2024 Mar; Vol. 31 (3), pp. 1789-1790. Date of Electronic Publication: 2024 Jan 11.
Autor:
Björklund J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Rautiola J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Zelic R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Edgren G; Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Cardiology, Södersjukhuset, Stockholm, Sweden., Bottai M; Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Nilsson M; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden., Vincent PH; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Fredholm H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Falconer H; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Sjövall A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Nilsson PJ; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Wiklund P; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York., Aly M; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Akre O; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Feb 05; Vol. 7 (2), pp. e2354352. Date of Electronic Publication: 2024 Feb 05.
Autor:
Droz-Vincent, Ph.
Directly interacting particles are considered in the multitime formalism of predictive relativistic mechanics. When the equations of motion leave a phase-space volume invariant, it turns out that the phase average of any first integral, covariantly d
Externí odkaz:
http://arxiv.org/abs/hep-th/9612124
Autor:
Droz-Vincent, Ph.1 philippe.drozvin@gmail.com
Publikováno v:
International Journal of Theoretical Physics. Sep2016, Vol. 55 Issue 9, p4124-4141. 18p.